can tirzepatide cause colitis GLP-1 Benefits For People With Ulcerative and Obesity The standard 2.5 mg starting

The findings, which have yet to be published, showed that Tirzepatide reduced participants risk of heart failure outcomes (hospitalization, death, and the need to increase medication dosage) by 38 percent compared with those taking placebo

They found that people who were treated with a GLP-1 agonist, like semaglutide, were less likely to have complications (such as hospitalization) due to IBD compared to people taking other diabetes medications

Acknowledgements Aakash Desai is the guarantor of the article

Coby Health is a legitimate telehealth platform that contracts with licensed, independent physicians and accredited compounding pharmacies

Evidence-based strategies focus primarily on preventing and managing gastrointestinal symptoms, maintaining hydration, and supporting patients through the adaptation period